Why ACRS? Aclaris Therapeutics, Inc. Analysis, Price & AI Insights | Whystock
ACRS
$4.41+0.07 (+1.61%)
Market ClosedLast close May 1
Aclaris Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering and developing novel molecule product candidates for immuno-inflammatory diseases in the United States.